F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Sustained virologic response

Page 1 of 1 ( 32 items )
<<
1
>>

1	Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study 11/27/2025 7:53:58 AM \| Browse: 36 \| Download: 167
2	Gender disparities in hepatitis C treatment: A call for tailored approaches 9/25/2025 11:24:00 AM \| Browse: 83 \| Download: 133
3	Shear-wave elastography to predict hepatocellular carcinoma after hepatitis C virus eradication: A systematic review and meta-analysis 3/14/2024 5:31:17 PM \| Browse: 195 \| Download: 1051
4	Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil 8/22/2023 7:39:26 AM \| Browse: 337 \| Download: 1317
5	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 533 \| Download: 1728
6	Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients 12/2/2022 9:49:51 AM \| Browse: 609 \| Download: 1563
7	Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study 8/10/2022 8:23:14 AM \| Browse: 589 \| Download: 2063
8	Hepatitis C virus burden: Treating and educating people without prejudice 7/27/2022 1:17:38 PM \| Browse: 634 \| Download: 1948
9	Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy 3/24/2022 2:13:21 PM \| Browse: 655 \| Download: 2034
10	Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections 3/17/2022 3:25:03 AM \| Browse: 583 \| Download: 1691
11	Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate 2/23/2022 3:51:55 PM \| Browse: 615 \| Download: 1860
12	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 701 \| Download: 1771
13	Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication 12/31/2021 12:21:18 PM \| Browse: 863 \| Download: 2525
14	Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long? 10/27/2021 7:14:11 AM \| Browse: 784 \| Download: 1636
15	Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan 9/29/2021 11:12:00 AM \| Browse: 614 \| Download: 1913
16	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 624 \| Download: 1899
17	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 689 \| Download: 1641
18	M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals 6/6/2020 2:43:56 PM \| Browse: 1383 \| Download: 2969
19	Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 10/28/2019 11:23:12 AM \| Browse: 1177 \| Download: 2882
20	Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions 8/7/2019 7:09:17 AM \| Browse: 1286 \| Download: 2334
21	Hepatitis C virus cure with direct-acting antivirals: Clinical, economic, societal and patient value for China 5/27/2019 8:24:36 AM \| Browse: 1209 \| Download: 2341
22	Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response 12/27/2018 9:28:07 AM \| Browse: 1278 \| Download: 1768
23	Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection 4/13/2017 3:45:15 PM \| Browse: 1480 \| Download: 2926
24	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1284 \| Download: 2802
25	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1464 \| Download: 3059
26	Treatment strategies for chronic hepatitis C prior to and following liver transplantation 1/7/2016 12:14:00 PM \| Browse: 1255 \| Download: 2050
27	Update on hepatitis C: Direct-acting antivirals 12/4/2015 3:24:00 PM \| Browse: 1327 \| Download: 2350
28	Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? 8/13/2015 10:30:00 AM \| Browse: 1434 \| Download: 2249
29	Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients 8/8/2015 3:25:00 PM \| Browse: 1320 \| Download: 2943
30	Predictive factors associated with hepatitis C antiviral therapy response 6/29/2015 5:40:00 PM \| Browse: 1369 \| Download: 2319
31	Interferon-3 polymorphisms in pegylated-interferon- plus ribavirin therapy for genotype-2 chronic hepatitis C 4/7/2015 6:08:00 PM \| Browse: 1182 \| Download: 2250
32	Sofosbuvir and ABT-450: Terminator of hepatitis C virus? 9/16/2014 9:54:00 AM \| Browse: 1599 \| Download: 1636

Page 1 of 1 ( 32 items )
<<
1
>>

1	Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study 11/27/2025 7:53:58 AM \| Browse: 36 \| Download: 167
2	Gender disparities in hepatitis C treatment: A call for tailored approaches 9/25/2025 11:24:00 AM \| Browse: 83 \| Download: 133
3	Shear-wave elastography to predict hepatocellular carcinoma after hepatitis C virus eradication: A systematic review and meta-analysis 3/14/2024 5:31:17 PM \| Browse: 195 \| Download: 1051
4	Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil 8/22/2023 7:39:26 AM \| Browse: 337 \| Download: 1317
5	Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C 12/2/2022 12:50:19 PM \| Browse: 533 \| Download: 1728
6	Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients 12/2/2022 9:49:51 AM \| Browse: 609 \| Download: 1563
7	Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study 8/10/2022 8:23:14 AM \| Browse: 589 \| Download: 2063
8	Hepatitis C virus burden: Treating and educating people without prejudice 7/27/2022 1:17:38 PM \| Browse: 634 \| Download: 1948
9	Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy 3/24/2022 2:13:21 PM \| Browse: 655 \| Download: 2034
10	Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections 3/17/2022 3:25:03 AM \| Browse: 583 \| Download: 1691
11	Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate 2/23/2022 3:51:55 PM \| Browse: 615 \| Download: 1860
12	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 701 \| Download: 1771
13	Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication 12/31/2021 12:21:18 PM \| Browse: 863 \| Download: 2525
14	Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long? 10/27/2021 7:14:11 AM \| Browse: 784 \| Download: 1636
15	Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan 9/29/2021 11:12:00 AM \| Browse: 614 \| Download: 1913
16	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 624 \| Download: 1899
17	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 689 \| Download: 1641
18	M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals 6/6/2020 2:43:56 PM \| Browse: 1383 \| Download: 2969
19	Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 10/28/2019 11:23:12 AM \| Browse: 1177 \| Download: 2882
20	Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions 8/7/2019 7:09:17 AM \| Browse: 1286 \| Download: 2334
21	Hepatitis C virus cure with direct-acting antivirals: Clinical, economic, societal and patient value for China 5/27/2019 8:24:36 AM \| Browse: 1209 \| Download: 2341
22	Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response 12/27/2018 9:28:07 AM \| Browse: 1278 \| Download: 1768
23	Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection 4/13/2017 3:45:15 PM \| Browse: 1480 \| Download: 2926
24	Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country 11/18/2016 3:13:00 PM \| Browse: 1284 \| Download: 2802
25	Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia 2/22/2016 3:38:00 PM \| Browse: 1464 \| Download: 3059
26	Treatment strategies for chronic hepatitis C prior to and following liver transplantation 1/7/2016 12:14:00 PM \| Browse: 1255 \| Download: 2050
27	Update on hepatitis C: Direct-acting antivirals 12/4/2015 3:24:00 PM \| Browse: 1327 \| Download: 2350
28	Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C? 8/13/2015 10:30:00 AM \| Browse: 1434 \| Download: 2249
29	Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients 8/8/2015 3:25:00 PM \| Browse: 1320 \| Download: 2943
30	Predictive factors associated with hepatitis C antiviral therapy response 6/29/2015 5:40:00 PM \| Browse: 1369 \| Download: 2319
31	Interferon-3 polymorphisms in pegylated-interferon- plus ribavirin therapy for genotype-2 chronic hepatitis C 4/7/2015 6:08:00 PM \| Browse: 1182 \| Download: 2250
32	Sofosbuvir and ABT-450: Terminator of hepatitis C virus? 9/16/2014 9:54:00 AM \| Browse: 1599 \| Download: 1636